the expression of DIABLO and AURKA was negatively associated with the prognosis of CM patients, while ZBP1, GNLY, FASLG, TNFRSF21, and CD40LG were positively associated with survival (Figure 8V–AB). The gene discussed is DIABLO; the disease is cutaneous mastocytosis.